Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 4
Submit an article Journal homepage
231
Views
2
CrossRef citations to date
0
Altmetric
Commentaries

T-cell prolymphocytic leukemia: survival improves with alemtuzemab, but stem cell transplant eligibility ‘counts’ even more

Estella MatutesHaematopathology Unit, Hospital Clinic of Barcelona, Spain and Correspondence[email protected]
&
Aaron PolliackDepartment of Hematology, Hadassah University Hospital and Hebrew University Medical School, Jerusalem, Israel
Pages 746-747 | Published online: 17 Sep 2015

References

  • Pileri SA, Milani M, Fraternali-Orcioni G, et al. From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities? Ann Oncol 1998;9:607–612.
  • Catovsky D, Muller-Hermelink HK, Ralfkiaer E. T-cell prolymphocytic leukaemia. In: Swerdlow SH, Campo E, Harris NC, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues (4th ed.). Lyon: International Agency for Research on Cancer (IARC); 2008. p 270–271.
  • Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991;78:3269–3274.
  • Garand R, Goasguen J, Brizard A, et al. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Francais d’Hematologie Cellulaire. Br J Haematol 1998;103:488–494.
  • Rashidi A, Fischer SI. T-cell chronic lymphocytic leukemia or small cell variant of T-cell prolymphocytic leukemia: a historical perspective and search for consensus. Eur J Haematol 2015;95:199–210.
  • Bergmann AK, Schneppenheim S, Seifert M, et al. Recurrent mutation of JAK3 in T-Cell prolymphocytic leukemia. Gene Chromosome Cancer 2014;53:309–316.
  • Kiel MJ, Velusamy T, Rolland D, et al. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. Blood 2014; 124:1460–1472.
  • Dearden C. How I treat prolymphocytic leukemia. Blood 2012;120:538–551.
  • Krishnan B, Else M, Tjonnfjord GE, et al. Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study. Br J Haematol 2010;149:896–918.
  • Guillaume T, Beguin Y, Tabrizi R, et al. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC). Eur J Haematol 2015;94:265–269.
  • Chandran R, Gardiner S, Fenske T, et al. Survival trends in T cell prolymphocytic leukemia: a SEER database analysis. Leuk Lymphoma 2016;57:943–945

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.